Metrics as of 10/13/2026, 06:41 PM (Berlin time), refresh in progress.
Collegium Pharmaceutical Stock
Collegium Pharmaceutical, Inc.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- CEO
- Vikram Karnani
- Employees
- 423
- Market cap
- $708 M
- IPO
- 07/05/2015
Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain conditions. A prominent offering is Xtampza ER, an extended-release, oral…
Collegium Pharmaceutical stock: price history
1D
-1.0%
1W
-0.2%
1M
-4.0%
6M
-38.7%
YTD
-52.8%
1Y
-31.8%
2Y
-42.1%
5Y
+7.6%
10Y
+23.2%
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~25% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Collegium Pharmaceutical
Analyst assessment of Collegium Pharmaceutical
PRICE TARGET LOW
US$45.00
CONSENSUS
US$48.00
MEDIAN
US$48.50
PRICE TARGET HIGH
US$50.00
0
STRONG BUY
8
BUY
3
HOLD
1
SELL
0
STRONG SELL
12
TOTAL · Buy
As of: 09/09/2026
Collegium Pharmaceutical stock metrics
P/E
14.27
P/B
2.27
EV/EBITDA
3.03
RETURN ON EQUITY
-4.8%
NET MARGIN
-7.5%
DEBT/EQUITY
2.75
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
98.8%
FLOAT SHARES
32,048,790
AVG. DAILY VOLUME (30D)
848,088
Insider transactions (SEC)
SANTINI GINO
Freund John Gordon
BOHLIN GAREN G
SANTINI GINO
Freund John Gordon
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.0%
Forums (Reddit)
Institutional holders
Comparable stocks
Frequently asked questions about Collegium Pharmaceutical stock
What does Collegium Pharmaceutical do?
Collegium Pharmaceutical, Inc. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in United States.
The CEO is Vikram Karnani, the company employs around 423 people.
The IPO was on 07/05/2015; the stock trades on NASDAQ under the ticker COLL.
What do analysts say about Collegium Pharmaceutical stock?
12 analysts rate the stock, the consensus is Buy (as of 09/09/2026).
The average price target is US$48.00, ranging from US$45.00 to US$50.00, with a median of US$48.50.
This is an external assessment, not a statement by Market Jury.
When does Collegium Pharmaceutical report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 25% stronger than usual.
Does Collegium Pharmaceutical pay a dividend?
No, Collegium Pharmaceutical currently does not pay a dividend.
Which stocks are comparable to Collegium Pharmaceutical?
Comparable stocks include Zoetis, Viatris, Lantheus Holdings, Amneal Pharmaceuticals, Indivior Pharmaceuticals, Eton Pharmaceuticals, Pacira BioSciences and Amphastar Pharmaceuticals.
How can I get Collegium Pharmaceutical stock analyzed?
Clicking "Analyze stock" lets five strategies assess Collegium Pharmaceutical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.